Base4 Capital is a venture capital firm that focuses on investing in people transforming biology into information science, with a sector focus on Life Science, Digital Health, and Biotech. Their investment strategy typically involves Series A and Series B rounds.
33% of their portfolio is in Biotech & Life Sciences. They made 1 investments in the last 12 months. Their most common stage is series-a (67% of deals). Average disclosed round size is $21.3M (across 6 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Centivax, Inc. | Series A | $45M | Jul 2025 |
 Mana.bio | Seed | $19.5M | Oct 2023 |
| KKapu | Seed | $8M | Dec 2022 |
 BVNK | Series A | $40M | May 2022 |
| OOfferZen | Series A | $5.1M | Dec 2021 |
| FFoodByUs | Series A | $10M | Nov 2021 |
Top Co-Investors
NFX2 shared
Giant Ventures1 shared
firstminute capital1 shared
Founder Collective1 shared
LionBird Ventures1 shared
Amplify Partners1 shared
Future Fund1 shared
Bold Capital Partners1 shared
Kendall Capital Partners1 shared
Tiger Global Management1 shared
The Raba Partnership1 shared
Avenir Growth1 shared
Kingsway Capital1 shared
Nordstar1 shared
Concentric1 shared
Macquarie Capital1 shared
Last updated: 15 April 2026